Skip to content

Clinical trials

Phase 1 Coronary Artery Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 1 Clear all

98 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20033
20041
20052
20069
200710
20085
20095
201010
20114
20128
20134
20143
20152
20163
20171
20185
20193
20202
20214
20223
20231
20244
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed71
Unknown status10
Terminated8
Withdrawn6
Recruiting1
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Bayer3
Mayo Clinic3
Vanderbilt University3
Washington University School of Medicine3
Bioheart, Inc.2
Chong Kun Dang Pharmaceutical2
Cytori Therapeutics2
Eli Lilly and Company2
Fluoropharma, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease98
Myocardial Infarction10
Cardiovascular Diseases7
Coronary Disease7
Heart Diseases7
Heart Failure7
Atherosclerosis4
Myocardial Ischemia4
Acute Coronary Syndrome3
Hypercholesterolemia3

Trials

Showing 51 to 75 of 98. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.